Your browser doesn't support javascript.
loading
Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.
Frasca, Matthieu; Sabathe, Camille; Delaloge, Suzette; Galvin, Angeline; Patsouris, Anne; Levy, Christelle; Mouret-Reynier, Marie A; Desmoulins, Isabelle; Vanlemmens, Laurence; Bachelot, Thomas; Goncalves, Anthony; Perotin, Virginie; Uwer, Lionel; Frenel, Jean S; Ferrero, Jean M; Bouleuc, Carole; Eymard, Jean C; Dieras, Véronique; Leheurteur, Marianne; Petit, Thierry; Dalenc, Florence; Jaffre, Anne; Chevrot, Michaël; Courtinard, Coralie; Mathoulin-Pelissier, Simone.
Afiliação
  • Frasca M; University of Bordeaux, Inserm, Bordeaux Population Health Research Centre, Epicene Team, UMR 1219, 33000, Bordeaux, France; Department of Palliative Medicine, CHU Bordeaux, 33000, Bordeaux, France. Electronic address: matthieu.frasca@u-bordeaux.fr.
  • Sabathe C; University of Bordeaux, Inserm, Bordeaux Population Health Research Centre, Biostatistic Team, UMR 1219, 33000, Bordeaux, France.
  • Delaloge S; Department of Medical Oncology, Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France.
  • Galvin A; University of Bordeaux, Inserm, Bordeaux Population Health Research Centre, Epicene Team, UMR 1219, 33000, Bordeaux, France.
  • Patsouris A; Department of Medical Oncology, Institut de Cancérologie de L'Ouest - Paul Papin, 49933, Angers, France.
  • Levy C; Department of Medical Oncology, Centre François Baclesse, 3, Avenue Du Général Harris, 14076, Caen, France.
  • Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, 58 Rue Montalembert, 63011, Clermont-Ferrand, France.
  • Desmoulins I; Department of Medical Oncology, Centre Georges-Francois Leclerc, 1 Rue Professeur Marion, 21079, Dijon, France.
  • Vanlemmens L; Department of Medical Oncology, Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000, Lille, France.
  • Bachelot T; Department of Medical Oncology, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, 69008, Lyon, France.
  • Goncalves A; Department of Medical Oncology, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009, Marseille, France.
  • Perotin V; Department of Palliative Medicine, Institut Du Cancer de Montpellier, 208 Rue des Apothicaires, 34298, Montpellier, France.
  • Uwer L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, 6 Avenue de Bourgogne, 54519 Vandoeuvre-lès-Nancy, France.
  • Frenel JS; Department of Medical Oncology, Institut de Cancérologie de L'Ouest - René Gauducheau, Boulevard Professeur Jacques Monod, 44805, Nantes, France.
  • Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, 33 Avenue de Valambrose, 06189, Nice, France.
  • Bouleuc C; Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm; 75005, Paris & Saint-Cloud, France.
  • Eymard JC; Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, 1 Rue de Général Koenig, 51100, Reims, France.
  • Dieras V; Department of Medical Oncology, Centre Eugène Marquis, Avenue de La Bataille Flandres-Dunkerque, 35000, Rennes, France.
  • Leheurteur M; Department of Medical Oncology, Centre Henri Becquerel, Rue D'Amiens, 76000, Rouen, France.
  • Petit T; Department of Medical Oncology, Centre Paul Strauss, 3 Rue de La Porte de L'Hôpital, 67000, Strasbourg, France.
  • Dalenc F; Department of Medical Oncology, Institut Claudius Regaud - IUCT Oncopole, 1 Avenue Irène-Joliot-Curie, 31059, Toulouse, France.
  • Jaffre A; Department of Medical Information, Institut Bergonie, Comprehensive Cancer Centre, 33000, Bordeaux, France.
  • Chevrot M; Department of Research and Development, R&D Unicancer, 101 Rue de Tolbiac, 75654, Paris, France.
  • Courtinard C; Department of Research and Development, R&D Unicancer, 101 Rue de Tolbiac, 75654, Paris, France.
  • Mathoulin-Pelissier S; University of Bordeaux, Inserm, Bordeaux Population Health Research Centre, Epicene Team, UMR 1219, 33000, Bordeaux, France; INSERM CIC1401, Institut Bergonie, Comprehensive Cancer Centre, 33000, Bordeaux, France.
Eur J Cancer ; 137: 240-249, 2020 09.
Article em En | MEDLINE | ID: mdl-32805641
ABSTRACT

INTRODUCTION:

Patients with metastatic breast cancer (MBC) often require inpatient palliative care (IPC). However, mounting evidence suggests age-related disparities in palliative care delivery. This study aimed to assess the cumulative incidence function (CIF) of IPC delivery, as well as the influence of age.

METHODS:

The national ESME (Epidemio-Strategy-Medical-Economical)-MBC cohort includes consecutive MBC patients treated in 18 French Comprehensive Cancer Centres. ICD-10 palliative care coding was used for IPC identification.

RESULTS:

Our analysis included 12,375 patients, 5093 (41.2%) of whom were aged 65 or over. The median follow-up was 41.5 months (95% confidence interval [CI], 40.5-42.5). The CIF of IPC was 10.3% (95% CI, 10.2-10.4) and 24.8% (95% CI, 24.7-24.8) at 2 and 8 years, respectively. At 2 years, among triple-negative patients, young patients (<65 yo) had a higher CIF of IPC than older patients after adjusting for cancer characteristics, centre and period (65+/<65 ß = -0.05; 95% CI, -0.08 to -0.01). Among other tumour sub-types, older patients received short-term IPC more frequently than young patients (65+/<65 ß = 0.02; 95% CI, 0.01 to 0.03). At 8 years, outside large centres, IPC was delivered less frequently to older patients adjusted to cancer characteristics and period (65+/<65 ß = -0.03; 95% CI, -0.06 to -0.01).

CONCLUSION:

We found a relatively low CIF of IPC and that age influenced IPC delivery. Young triple-negative and older non-triple-negative patients needed more short-term IPCs. Older patients diagnosed outside large centres received less long-term IPC. These findings highlight the need for a wider implementation of IPC facilities and for more age-specific interventions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article